Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia
Summary
Ezetimibe is recommended as a possible treatment for adults with primary (heterozygous-familial and non-familial) hypercholesterolaemia in the following circumstances.
Ezetimibe can be taken on its own by a person who would normally be given a statin to treat their condition but can't because th ...
Read the complete summary
Ezetimibe is recommended as a possible treatment for adults with primary (heterozygous-familial and non-familial) hypercholesterolaemia in the following circumstances.
- Ezetimibe can be taken on its own by a person who would normally be given a statin to treat their condition but can't because the person has a condition or takes another medicine that interferes with how the statin works, or because the statin is likely to cause side effects.
- Ezetimibe can be taken at the same time as a person's usual statin rather than changing to a new statin when cholesterol levels are not low enough despite increasing the dose of the statin, or if a person is unable to try higher doses of the statin because it is likely to cause side effects.
When a person has side effects from using a statin, this is described as 'intolerance'. Side effects include muscle pain, severe stomach problems or when tests indicate that the liver is not functioning normally.
A decision on whether a person's cholesterol level is low enough should be based on an individual risk assessment.
If it is decided that a person should take their usual statin and ezetimibe together, then the least expensive form of ezetimibe should be prescribed.
hide
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in August 2010